In a collaborative study, researchers from the SN Bose National Centre for Basic Sciences, Kolkata, Uluberia College, University of Calcutta, and other institutes made an exciting discovery in treating ulcerative colitis, a prevalent chronic inflammatory bowel disease (IBD). By using chitosan-capped trimanganese tetraoxide nanoparticles, they effectively treated the disease in mice, offering the potential for future therapeutic advancements in this debilitating condition.
Unfazed by opposition from international community, Indian scientists propose a new use for nano-sized curcumin in reducing toxicity caused by anti-tuberculosis drugs and in preventing reinfection of tuberculosis.
Scientists use enzymes to convert lignin fibres from ridge-gourd into nanoparticles to be used in a variety of bio-products.
Researchers from Delhi enhance hydrogel dressings with silver nanoparticles to make them more effective against bacterial infection.
Madhukara Putty reports about a new study by researchers from the National Brain Research Centre, Manesar, Gurgaon and the Indian Association for the Cultivation of Science, Kolkata which shows that nanoparticles coated with histidine polymer get attached to amyloid fibrils and stop their growth completely.
Researchers from Mumbai have designed special nanostructures for targeted delivery of anti-malarial drugs. Harini Barath reports on investigations that attempt to understand how these nanostructures afford partial protection against the disease even when they are not loaded with drugs.
Researchers have developed a new sensor platform using nanomaterials to accurately detect C-reactive protein, high levels of which indicate increased risk of cardiovascular infections. Madhukara Putty tells us more about the new technique which holds promise for cheaper and more accurate diagnosis.